CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
38 hedge funds and large institutions have $85.1M invested in CTI BioPharma Corp. (DE) Common Stock in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
38
Holders Change
-5
Holders Change %
-11.63%
% of All Funds
0.77%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
5
Increased
10
Reduced
8
Closed
10
Calls
$541K
Puts
$122K
Net Calls
+$419K
Net Calls Change
+$385K
Top Buyers
1 |
CC
Caxton Corporation
Princeton,
New Jersey
|
+$7.94M |
2 |
Verition Fund Management
Greenwich,
Connecticut
|
+$1.66M |
3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.48M |
4 |
Two Sigma Investments
New York
|
+$297K |
5 |
Two Sigma Advisers
New York
|
+$280K |
Top Sellers
1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$644K |
2 |
Millennium Management
New York
|
-$71K |
3 |
UBS Group
Zurich,
Switzerland
|
-$43.2K |
4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$35K |
5 |
HF
HRT Financial
New York
|
-$22K |